Transient retinal artery occlusion

H7_RETARTOCCTRANS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H34.0 Cause of death: ICD-10 — H34.0 2 out of 7 registries used, show all original rules.	87
4. Check minimum number of events None	87
5. Include endpoints None	87
6. Filter based on genotype QC (FinnGen only)	79

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H34
Name in latin: Occlusio arteriae retinalis transitoria

NAME	H7_RETARTOCCTRANS
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H340
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H340
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Transient retinal artery occlusion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	494	232	259
Only index persons	457	219	238
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	69.25	71.14	67.63
Only index persons	68.72	70.55	67.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	79	40	39
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	65.25	64.18	66.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
80: Matched controls
800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H34.0

ICD-10 Finland

Transient retinal artery occlusion

+∞

115.1

H34.2

ICD-10 Finland

Other retinal artery occlusions

+∞

19.6

H34.8

ICD-10 Finland

Other retinal vascular occlusions

212.5

17.2

XCK10

NOMESCO Finland

Photography of fundus of eye

8.4

15.7

H34.1

ICD-10 Finland

Central retinal artery occlusion

+∞

15.1

CKC12

NOMESCO Finland

Photocoagulation of retina

167.2

13.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.2

11.0

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

12.5

10.2

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

41.9

9.3

XCD20

NOMESCO Finland

Photoangiography of eye

100.2

8.6

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

7.7

8.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

8.0

7.6

AA1AD

NOMESCO Finland

CT of head and brain

3.7

7.6

193

XCK00

NOMESCO Finland

Perimetry

8.0

7.3

G45.3

ICD-10 Finland

Amaurosis fugax

16.1

6.6

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

75.6

6.5

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4.09

3.47

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.81

3.44

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.38

3.44

1.4

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.98

3.28

2.2

0.21

0.20

g/l

0.10

(4195642) Thrombophilia screening test

10.54

3.02

1.2

1.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

324

2.20

2.93

7.1

4.7

35.66

34.93

g/l

0.48

312

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

7.10

2.92

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.32

2.64

2.6

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

7.52

2.58

1.0

2.0

12.20

13.86

u/l

—

(3019977) pH of Arterial blood

101

2.31

2.42

6.4

6.3

7.40

7.41

0.18

(3004789) Transferrin [Mass/volume] in Serum or Plasma

134

2.13

2.28

3.4

2.4

2.25

2.27

g/l

0.05

122

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

311

1.92

2.14

3.1

2.3

82.74

80.19

nmol/l

0.22

273

(3018418) pH of Serum or Plasma

250

1.89

2.04

4.8

4.4

7.40

0.02

170

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

4.77

1.97

1.0

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

2.15

1.95

5.6

3.3

1.75

1.65

0.19

(3032080) INR in Blood by Coagulation assay

348

1.85

1.90

34.0

15.0

1.43

1.28

inr

0.86

286

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

127

2.01

1.89

3.6

2.4

23.33

21.95

0.13

118

(3022948) Iron [Moles/volume] in Serum or Plasma

144

1.95

1.85

4.0

2.3

12.13

12.81

umol/l

0.16

131

(3015736) pH of Urine

322

1.81

1.82

6.2

3.8

6.30

6.22

0.18

170

(3021960) Folate [Moles/volume] in Serum or Plasma

239

1.83

1.82

1.9

1.7

18.03

19.87

nmol/l

0.41

188

(3000991) Gas panel - Venous blood

2.20

1.78

7.2

7.1

—

(3044290) Cell count panel - Cerebral spinal fluid

3.51

1.78

1.0

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3.51

1.78

2.8

1.5

104.50

99.22

—

(3000492) Spirometry study

2.31

1.77

1.9

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

4.03

1.74

1.0

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

4.03

1.74

1.0

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

147

1.90

1.74

2.1

1.7

1094.44

1262.73

nmol/l

0.32

107

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

157

1.86

1.67

3.2

3.0

2.45

2.47

mmol/l

0.31

142

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

339

1.75

1.63

2.6

2.1

92.42

93.98

pmol/l

0.09

155

(3020682) Albumin/Creatinine [Ratio] in Urine

246

1.75

1.61

5.9

4.0

15.78

7.35

mg/mmol

0.30

157

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.16

1.61

1.2

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.16

1.61

1.2

1.6

—

(21494755) Public health laboratory ask at order entry panel

0.00

1.57

0.0

1.7

—

(3012516) Albumin [Mass/volume] in Urine

241

1.71

1.50

5.4

3.2

76.20

42.01

mg/l

0.26

157

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

336

1.69

1.47

5.0

3.0

—

estimate

—

(3006504) Eosinophils/Leukocytes in Blood

336

1.69

1.47

9.0

6.3

2.83

2.76

0.09

315

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.26

1.46

1.0

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.26

1.46

2.6

1.6

172.20

207.81

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

3.26

1.46

1.6

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.93

1.45

9.2

5.9

1.08

1.06

mmol/l

0.10

(3019060) Gas panel - Arterial blood

2.20

1.40

5.5

3.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

301

1.66

1.39

5.4

4.4

37.85

36.79

ng/l

0.02

222

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

681

2.62

1.38

28.1

17.7

25.02

25.23

mg/l

0.02

573

(3014576) Chloride [Moles/volume] in Serum or Plasma

124

1.82

1.37

6.9

5.8

103.05

104.15

mmol/l

0.41

124

(3019069) Monocytes/Leukocytes in Blood

340

1.65

1.37

9.0

6.5

8.76

8.80

0.04

318

(3004588) Protein electrophoresis panel - Serum or Plasma

2.06

1.31

1.2

2.2

—

(3018010) Neutrophils/Leukocytes in Blood

343

1.63

1.31

9.2

6.2

59.47

58.03

0.39

325

(3035350) Ketones [Presence] in Urine by Test strip

403

1.64

1.29

7.1

4.1

0.00

estimate

-0.00

(3002030) Lymphocytes/Leukocytes in Blood

344

1.62

1.28

9.5

6.5

26.05

26.89

0.21

326

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

135

1.75

1.28

5.4

3.1

2.40

2.68

e6/l

—

(3001604) Monocytes [#/volume] in Blood

364

1.62

1.27

8.4

6.0

0.57

0.59

e9/l

0.12

311

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.51

1.27

1.7

2.0

0.23

0.24

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.51

1.27

1.7

2.1

1.12

1.19

g/l

—

(3020891) Body temperature

2.29

1.25

5.5

4.4

36.85

36.91

°c

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

145

1.71

1.23

5.3

3.0

0.73

1.02

e6/l

—

(3019198) Lymphocytes [#/volume] in Blood

376

1.61

1.23

8.7

5.9

1.86

1.79

e9/l

0.26

334

(3009261) Glucose [Presence] in Urine by Test strip

406

1.62

1.23

7.2

4.1

0.00

estimate

—

(3022096) Basophils/Leukocytes in Blood

337

1.60

1.22

9.2

6.3

0.72

0.68

0.19

313

(3002582) Erythrocytes [#/volume] in Urine

280

1.60

1.22

6.9

3.1

24.18

45.76

e6/l

0.72

202

(3044640) Blood type and Crossmatch panel - Blood

243

1.61

1.21

5.0

2.6

—

(3006315) Basophils [#/volume] in Blood

368

1.59

1.19

8.4

6.0

0.04

e9/l

0.12

315

(3030467) Casts [#/volume] in Urine by Automated count

245

1.59

1.17

5.1

3.0

0.08

0.33

e6/l

1.88

169

(3021601) Nitrite [Presence] in Urine by Test strip

400

1.58

1.15

7.2

4.1

0.00

estimate

-0.00

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

237

1.58

1.14

4.1

3.2

1116.15

1566.07

ng/l

0.57

200

(3019150) Specific gravity of Urine by Refractometry

157

1.65

1.13

7.3

4.5

1.02

kg/l

0.74

102

(40761511) CBC panel - Blood by Automated count

695

2.26

1.11

23.1

15.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.47

1.10

1.6

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

295

1.55

1.09

7.1

3.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.03

1.06

1.8

1.6

—

(3008898) HLA-B27 [Presence]

2.35

1.05

1.2

—

(42870588) Differential panel, method unspecified - Blood

241

1.55

1.04

8.2

5.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

427

1.54

1.01

12.0

9.5

3.97

4.32

e9/l

0.70

368

(3013115) Eosinophils [#/volume] in Blood

378

1.51

0.99

8.8

6.1

0.20

0.19

e9/l

0.11

328

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

226

1.52

0.97

3.4

2.8

60.67

56.14

u/l

0.43

206

(3023520) Reticulocytes [#/volume] in Blood

1.81

0.95

3.4

3.3

72.41

68.11

e9/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

182

1.54

0.93

2.8

2.6

—

(3018095) Leukocytes [#/volume] in Urine

304

1.48

0.91

8.7

3.8

15.27

95.53

e6/l

1.82

207

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

296

1.47

0.88

7.5

4.3

0.00

estimate

-0.00

(36304419) Bacteria [Presence] in Urine

232

1.47

0.84

5.6

3.0

—

estimate

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.76

0.76

1.9

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.15

0.76

2.6

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.73

0.70

1.6

1.5

—

(3021589) Normoblasts [#/volume] in Blood

328

1.37

0.65

15.2

12.2

0.00

e9/l

0.50

267

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.77

0.65

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.67

0.64

1.9

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

400

1.35

0.61

8.1

6.8

10.83

11.95

umol/l

0.45

376

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.61

0.0

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.57

0.61

5.3

3.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.57

0.60

2.9

2.5

0.74

0.68

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.53

0.59

2.9

2.6

1.30

1.14

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

632

1.51

0.58

5.4

4.6

1.34

1.26

mmol/l

0.48

570

(3002256) Pathology report gross observation

108

1.48

0.58

1.6

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

218

1.36

0.57

9.2

3.7

0.00

estimate

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.54

0.54

2.1

1.6

—

(40758558) Short blood count panel - Blood

221

1.33

0.52

7.1

6.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.54

0.49

2.6

4.5

1.25

1.23

mmol/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

242

1.31

0.49

3.3

2.9

26.31

33.77

u/l

1.45

229

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.50

0.45

4.6

4.7

26.26

25.17

mmol/l

—

(4024509) Urine culture

1.65

0.44

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

1.58

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

0.93

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

680

1.39

0.38

7.1

6.2

2.43

2.64

mmol/l

1.35

618

(3023368) Bacteria identified in Blood by Culture

232

1.25

0.35

5.1

4.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.71

0.33

1.7

1.5

—

(3042936) Bacteria identified in Isolate by Culture

111

1.32

0.33

2.4

1.7

—

(3022145) Colonoscopy Study observation

1.36

0.32

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.32

0.31

1.1

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

217

1.22

0.29

5.1

4.7

24.23

22.49

0.21

108

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.34

0.27

2.3

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

663

1.30

0.27

6.4

5.4

6.35

5.99

mmol/l

0.61

603

(40760892) CBC W Ordered Manual Differential panel - Blood

162

1.23

0.26

7.0

5.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

163

1.22

0.24

1.6

1.2

0.40

1.07

u/ml

—

(3026008) Bacteria identified in Urine by Culture

252

1.17

0.22

5.3

3.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.2

—

(1761868) Lipid panel - Serum or Plasma

257

0.85

0.21

4.9

3.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.24

0.20

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.26

0.20

1.8

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.26

0.20

2.5

1.6

—

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.2

—

(36660697) Celiac disease serology panel - Serum

1.22

0.20

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

194

0.84

0.19

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.25

0.19

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.21

0.15

4.1

2.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

152

1.15

0.13

1.9

1.4

1.48

2.94

g/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

663

1.17

0.13

6.4

5.3

1.40

1.45

mmol/l

0.59

601

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.19

0.11

8.0

7.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.07

0.09

3.8

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.16

0.09

4.1

1.9

—

(40761536) Microorganisms panel - Urine sediment

0.83

0.08

12.2

3.8

—

(4035726) Immunohistochemistry procedure

0.81

0.08

1.2

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.11

0.08

3.9

2.0

248.25

415.10

nmol/l

—

(40768804) Tissue Pathology biopsy report

276

1.08

0.07

3.1

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

237

1.08

0.06

8.3

4.0

0.00

estimate

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

169

1.08

0.05

2.8

1.8

321.31

442.35

pmol/l

1.30

141

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

389

1.06

0.04

3.5

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

639

0.93

0.03

7.1

5.3

2.04

1.97

mu/l

0.17

571

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

289

0.95

0.03

2.2

1.9

1.42

1.30

mmol/l

0.29

223

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

133

0.97

0.00

3.8

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

106

1.04

0.00

2.6

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

3.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

8.48

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

0.0

2.3

—

31.85

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.4

—

58.80

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

88.67

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

3.0

—

5.53

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.6

—

9.88

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.4

—

13.20

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.6

—

4.64

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

0.96

-0.00

1.7

2.4

3.97

4.18

e9/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.8

—

31.13

—

(40768797) Stomach Pathology biopsy report

100

1.00

-0.00

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3000494) Fungus identified in Specimen by Culture

0.91

-0.00

3.4

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_RETARTOCCTRANS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_RETARTOCCTRANS	1.193 [0.88, 1.61]	0.248
Birth year	0.994 [0.99, 1.0]	0.183

During the follow-up period (1.1.1998 — 31.12.2019), 70 out of 215 females with H7_RETARTOCCTRANS died.

Males

Parameter	HR [95% CI]	p-value
H7_RETARTOCCTRANS	1.48 [1.11, 1.98]	0.008
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 228 males with H7_RETARTOCCTRANS died.

Mortality risk

Mortality risk for people of age

years, who have H7_RETARTOCCTRANS.

N-year risk	Females	Males
1	0.125%	0.28%
5	0.736%	1.675%
10	1.684%	4.116%
15	3.186%	7.73%
20	5.643%	12.837%

Relationships between endpoints

↥

Index endpoint: H7_RETARTOCCTRANS – Transient retinal artery occlusion

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Transient retinal artery occlusion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints